Sara Bonstein

2018 - OncoSec Medical

In 2018, Sara Bonstein earned a total compensation of $919.2K as Chief Financial Officer and Chief Operating Officer at OncoSec Medical.

Compensation breakdown

Bonus$75,000
Salary$6,731
Stock Awards$837,500
Total$919,231

Bonstein received $837.5K in stock awards, accounting for 91% of the total pay in 2018.

Bonstein also received $75K in bonus and $6.7K in salary.

Rankings

In 2018, Sara Bonstein's compensation ranked 9,602nd out of 14,244 executives tracked by ExecPay. In other words, Bonstein earned more than 32.6% of executives.

ClassificationRankingPercentile
All
9,602
out of 14,244
33rd
Division
Manufacturing
3,860
out of 5,759
33rd
Major group
Chemicals And Allied Products
1,455
out of 2,122
31st
Industry group
Drugs
1,225
out of 1,811
32nd
Industry
Pharmaceutical Preparations
944
out of 1,385
32nd
Source: SEC filing on November 8, 2018.

Bonstein's colleagues

We found three more compensation records of executives who worked with Sara Bonstein at OncoSec Medical in 2018.

2018

Daniel O'Connor

OncoSec Medical

Chief Executive Officer

2018

Punit Dhillon

OncoSec Medical

Chief Executive Officer

2018

Richard Slansky

OncoSec Medical

Chief Financial Officer

News

You may also like